Amitifadine, a triple monoamine uptake inhibitor, reduces binge drinking and negative affect in an animal model of co-occurring alcoholism and depression symptomatology

► Triple-reuptake inhibitor alters co-occurring alcoholism and depression. ► Triple-reuptake inhibitor selectively decreased binge drinking. ► Triple-reuptake inhibitor decreased depression symptomatology.